Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
10 p, 389.9 KB A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation / Nevens, Frederik (University Hospitals Leuven (Bèlgica)) ; Gustot, Thierry (C.U.B. Erasme Hospital) ; Laterre, Pierre-François (Cliniques Universitaires Saint-Luc) ; Lasser, Luc L. (CHU Brugmann) ; Haralampiev, Lyudmil E. (Multiprofile Hospital for Active Treatment (MEDICA), Ruse) ; Vargas, Victor (Hospital Universitari Vall d'Hebron) ; Lyubomirova, Desislava (University Multiprofile Hospital for Active Treatment "Georgi Stranski") ; Albillos, Agustín (Hospital Universitario Ramón y Cajal (Madrid)) ; Najimi, Mustapha (Institute of Experimental and Clinical Research, Brussels) ; Michel, Sébastien (Promethera Biosciences, Mont-Saint-Guibert) ; Stoykov, Ivaylo (Promethera Biosciences, Mont-Saint-Guibert) ; Gordillo, Noelia (Promethera Biosciences, Mont-Saint-Guibert) ; Vainilovich, Yelena (Promethera Biosciences, Mont-Saint-Guibert) ; Barthel, Virginie (Promethera Biosciences, Mont-Saint-Guibert) ; Clerget-Chossat, Nathalie (Promethera Biosciences, Mont-Saint-Guibert) ; Sokal, Etienne M. (Cliniques Universitaires Saint-Luc, UCLouvain, Pediatric Hepatology & Gastroenterology Unit) ; Universitat Autònoma de Barcelona
Human allogeneic liver-derived progenitor cells (HALPC, HepaStem®; Promethera Biosciences, Mont-Saint-Guibert, Belgium) are an advanced therapy medicinal product that could potentially alleviate systemic inflammation and ameliorate liver function in patients with acute-on-chronic liver failure (ACLF) or acute decompensation of cirrhosis (AD). [...]
2021 - 10.1016/j.jhepr.2021.100291
JHEP Reports, Vol. 3 (april 2021)  

Vegeu també: autors amb noms similars
1 Sokal, E.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.